Clinical Trial Update: Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes [NA]

View source ↗

Summary

A completed clinical trial comparing the Hydrus Microstent to two iStents for lowering intraocular pressure in phakic eyes with glaucoma has results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma
• Pigmentary Glaucoma
• Pseudoexfoliative Glaucoma

Drugs mentioned

• Hydrus Microstent
• iStent

Snippet

Sponsor: Ivantis, Inc. | Conditions: Primary Open Angle Glaucoma, Pseudoexfoliative Glaucoma | NA | Status: COMPLETED | Results posted: 2019-12-10